Effectiveness of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2.2 Infection in Beijing, China, 2022: A Cohabitation Retrospective Cohort Study

Effectiveness of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2.2 Infection in Beijing, China, 2022: A Cohabitation Retrospective Cohort Study

The present study aimed to evaluate the vaccine effectiveness (VE) of different doses of an inactivated coronavirus disease 2019 (COVID-19) vaccine against Omicron BA.2.2 infection in Beijing, China, 2022. Based on data from a previous cohabitation retrospective cohort of COVID-19 outbreak in Beijin...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shuaibing Dong, Ying Sun, Zhaomin Feng, Yi Tian, Lei Jia, Xiaoli Wang, Quanyi Wang, Daitao Zhang, Peng Yang
Format:	Article
Language:	English
Published:	MDPI AG 2024-12-01
Series:	Viruses
Subjects:	Omicron BA.2.2 inactivated COVID-19 vaccines vaccine effectiveness COVID-19 pandemic booster immunization China
Online Access:	https://www.mdpi.com/1999-4915/17/1/31
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development of a Recombinant Omicron BA.1 Subunit Vaccine Candidate in Pichia pastoris
by: Sibel Kalyoncu, et al.
Published: (2025-01-01)

COVID-19 Vaccine Booster Dose Fails to Enhance Antibody Response to Omicron Variant in Reinfected Healthcare Workers
by: Leire Fernández-Ciriza, et al.
Published: (2025-01-01)

Combined mutations in nonstructural protein 14, envelope, and membrane proteins mitigate the neuropathogenicity of SARS-CoV-2 Omicron BA.1 in K18-hACE2 mice
by: Kotou Sangare, et al.
Published: (2025-01-01)

The immune landscape and viral shedding of Omicron SARS-CoV-2 variants implicate immune escape
by: Weilong Zhang, et al.
Published: (2025-01-01)

Comparing Antibody Responses to Homologous vs. Heterologous COVID-19 Vaccination: A Cross-Sectional Analysis in an Urban Bangladeshi Population
by: Kazi Istiaque Sanin, et al.
Published: (2025-01-01)

Strategic Health Diplomacy: An Indonesia’s Approach in Securing COVID-19 Booster Vaccine Supplies
by: Deasy Silvya Sari, et al.
Published: (2024-06-01)

Waning neutralizing antibodies through 180 days after homologous and heterologous boosters of inactivated COVID-19 vaccine
by: Zhifei Chen, et al.
Published: (2025-01-01)

Re-presentations to the emergency department initial presentation with COVID-19: Insights from the omicron wave
by: Daniella Audish, et al.
Published: (2025-03-01)

Next generation sequencing of multiple SARS-CoV-2 infections in the Omicron Era
by: Marzia Cavalli, et al.
Published: (2025-01-01)

Fusion protein-based COVID-19 vaccines exemplified by a chimeric vaccine based on a single fusion protein (W-PreS-O)
by: Pia Gattinger, et al.
Published: (2025-01-01)

Does the COVID-19 XBB Omicron subvariant signal the beginning of the end of the pandemic?
by: Jinghao Nicholas Ngiam, et al.
Published: (2024-12-01)

ATTITUDES TOWARD COVID-19 BOOSTER DOSE VACCINES ACCEPTANCEAMONG HEALTHCARE STUDENTS, KARACHI: A CROSS-SECTIONALANALYSIS
by: Arif Ali, et al.
Published: (2024-12-01)

Uptake and hesitancy of the second booster dose of COVID-19 vaccine among the general population in China after the surge period of the COVID-19 pandemic: a large-scale national study
by: Xin Liu, et al.
Published: (2025-02-01)

Clinical outcomes of early remdesivir administration in hospitalized patients at high risk for severe COVID-19 during the Omicron wave
by: Yeon Ju La, et al.
Published: (2025-02-01)

Difference of SARS-CoV-2 infection and influence factors between people with and without HIV infection
by: Jianhui Yang, et al.
Published: (2025-01-01)

Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platformResearch in context
by: Jennifer L. Nguyen, et al.
Published: (2025-01-01)

Altered expression of miRNA profile in peripheral blood mononuclear cells following the third dose of inactivated COVID-19 vaccine
by: Guanguan Qiu, et al.
Published: (2025-01-01)

Omicron Positivity in Air of Hospital Settings Gathered COVID-19 Patients, Vaccinated/Unvaccinated Populations
by: Zeynep Ece Kuloğlu, et al.
Published: (2023-06-01)

Early COVID-19 and protection from Omicron in a highly vaccinated population in Ontario, Canada: a matched prospective cohort study
by: Altynay Shigayeva, et al.
Published: (2025-02-01)

Efficacy of BNT162b2 and CoronaVac in patients diagnosed with COVID-19
by: Dogan Mustafa, et al.
Published: (2023-06-01)

Two Years of SARS-CoV-2 Omicron Genomic Evolution in Brazil (2022–2024): Subvariant Tracking and Assessment of Regional Sequencing Efforts
by: Ueric José Borges de Souza, et al.
Published: (2025-01-01)

Optimization of RHDV type 1 and 2 inactivation modes
by: E. D. Kunikova, et al.
Published: (2021-03-01)

mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
by: A. A. Ilyichev, et al.
Published: (2020-12-01)

Vaccination and Mortality of Patients with a Novel Coronavirus Infection (COVID-19): A Global Approach
by: N. A. Benuni, et al.
Published: (2022-09-01)

Antibody response against an inactive SARS-CoV-2 vaccine among healthcare workers occupied in different divisions
by: Feridun Gürlek, et al.
Published: (2024-06-01)

THE EFFECT OF VACCINATON ON COVID-19 DEATHS: A RESEARCH ACCORDING TO COUNTRIES' INCOME GROUPS
by: Durmuş Gökkaya, et al.
Published: (2023-03-01)

Mucosal Immunization with an Influenza Vector Carrying SARS-CoV-2 N Protein Protects Naïve Mice and Prevents Disease Enhancement in Seropositive Th2-Prone Mice
by: Mariia V. Sergeeva, et al.
Published: (2024-12-01)

OPTIMIZATION OF MEDICAL EVALUATION STRATEGIES IN VACCINATED WOMEN ANTI COVID-19, IN ROMANIA, TO IMPROVE THE LEVEL OF HESITATION AGAINST THE BENEFIT OF VACCINATION
by: Andreea Roxana Luca, et al.
Published: (2024-12-01)

Safety and immunogenicity of Ad26.COV2.S in adolescents: Phase 2 randomized clinical trial
by: Jelena Tica, et al.
Published: (2025-12-01)

Reflections on COVID-19: A Literature Review of SARS-CoV-2 Testing
by: Chin Shern Lau, et al.
Published: (2024-12-01)

COVID-19 Vaccine Hesitancy Among Various Segments of the Population in Turkey: A Literature Review
by: Sezer Okay
Published: (2025-01-01)

Estimating the Effectiveness of Pfizer and Sinopharm Vaccines and their Relationship to Occupation, Residence, Smoking, and Body Mass Index During Pregnancy Smoking
by: Shahad Th. Jameel, et al.
Published: (2025-01-01)

Experience of COVID-19 vaccination among healthcare workers in Iran: a descriptive phenomenological study
by: Atefeh Torknejad, et al.
Published: (2025-01-01)

Vaccination Against SARS-Cov-2 among Patients with Parkinson’s Disease Based on the Results of COVPARK-LT Study
by: R. Kaladytė Lokominienė, et al.
Published: (2024-02-01)

COVID-19-related stress, anxiety and vaccine hesitancy among healthcare workers in a tertiary hospital in South-Western Nigeria
by: Temitope Olumuyiwa Ojo, et al.
Published: (2025-02-01)

Strategies and resources used by public health units to encourage COVID-19 vaccination among priority groups: a behavioural science-informed review of three urban centres in Canada
by: Tori Langmuir, et al.
Published: (2025-01-01)

Case report: Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series
by: Maris Taube, et al.
Published: (2025-01-01)

COVID-19 Vaccination Status and Pregnancy Outcome during Third Wave
by: Madhusudan Dey, et al.
Published: (2023-08-01)

SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development
by: Fabrizio Angius, et al.
Published: (2024-12-01)

The Impact of Effective Vaccination on Clinical and Radiological Involvement in COVID-19 Patients
by: Coskun DOGAN, et al.
Published: (2023-12-01)